about
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trialEnteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 RVTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial.Phase 1/2 study of carfilzomib plus melphalan and prednisone in patients aged over 65 years with newly diagnosed multiple myeloma.
P50
description
onderzoeker
@nl
name
Carine Chaleteix
@ast
Carine Chaleteix
@en
Carine Chaleteix
@es
Carine Chaleteix
@sl
type
label
Carine Chaleteix
@ast
Carine Chaleteix
@en
Carine Chaleteix
@es
Carine Chaleteix
@sl
prefLabel
Carine Chaleteix
@ast
Carine Chaleteix
@en
Carine Chaleteix
@es
Carine Chaleteix
@sl